M Tsuboshima

512 total citations
12 papers, 443 citations indexed

About

M Tsuboshima is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, M Tsuboshima has authored 12 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Biochemistry. Recurrent topics in M Tsuboshima's work include Inflammatory mediators and NSAID effects (5 papers), Synthesis of β-Lactam Compounds (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). M Tsuboshima is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Synthesis of β-Lactam Compounds (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). M Tsuboshima collaborates with scholars based in Japan. M Tsuboshima's co-authors include Hiroshi Terashima, Ikuo Hatanaka, Ryuichi Kikkawa, Y. Shigeta, Reiko Yamamoto, K. Hama, Arao Ujiie, A Kawasaki, Shuichiro Hamano and Jun Naito and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Diabetologia and European Journal of Pharmacology.

In The Last Decade

M Tsuboshima

12 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Tsuboshima Japan	9	163	152	112	109	56	12	443
Buichi Fujitani Japan	14	70 0.4×	52 0.3×	103 0.9×	224 2.1×	117 2.1×	46	649
Mauro Miceli Italy	12	98 0.6×	142 0.9×	40 0.4×	92 0.8×	99 1.8×	13	420
Brenda R. Flam United States	11	224 1.4×	89 0.6×	33 0.3×	251 2.3×	47 0.8×	13	599
Donald J. Mirrlees United Kingdom	11	193 1.2×	151 1.0×	49 0.4×	157 1.4×	21 0.4×	13	468
Masahiro Mizota Japan	15	80 0.5×	56 0.4×	56 0.5×	125 1.1×	33 0.6×	38	430
James P. Chovan United States	15	200 1.2×	243 1.6×	33 0.3×	147 1.3×	45 0.8×	22	568
Animesh Chandra United States	11	174 1.1×	282 1.9×	41 0.4×	352 3.2×	71 1.3×	16	648
Stacy A. Hazen United States	9	99 0.6×	52 0.3×	61 0.5×	229 2.1×	54 1.0×	10	428
P D Dawkins United States	12	39 0.2×	36 0.2×	124 1.1×	140 1.3×	30 0.5×	19	452
Armel Fradin France	10	89 0.5×	43 0.3×	91 0.8×	249 2.3×	16 0.3×	14	524

Countries citing papers authored by M Tsuboshima

Since Specialization

Citations

This map shows the geographic impact of M Tsuboshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Tsuboshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Tsuboshima more than expected).

Fields of papers citing papers by M Tsuboshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Tsuboshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Tsuboshima. The network helps show where M Tsuboshima may publish in the future.

Co-authorship network of co-authors of M Tsuboshima

This figure shows the co-authorship network connecting the top 25 collaborators of M Tsuboshima. A scholar is included among the top collaborators of M Tsuboshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Tsuboshima. M Tsuboshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tsuboshima, M, et al.. (1992). Prostaglandins : Synthetic and Pharmacological Studies and Development. YAKUGAKU ZASSHI. 112(7). 447–469. 3 indexed citations

Terashima, Hiroshi, K. Hama, Reiko Yamamoto, et al.. (1984). Effects of a new aldose reductase inhibitor on various tissues in vitro.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 226–230. 126 indexed citations

Wakitani, K., Nobuo Katsube, A Kawasaki, et al.. (1983). Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.. PubMed. 11. 241–4. 8 indexed citations

Naito, Jun, et al.. (1983). Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. European Journal of Pharmacology. 91(1). 41–48. 89 indexed citations

Katsura, Masashi, Nobuyuki Hamanaka, Kazuoki Kondo, et al.. (1983). In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).. PubMed. 11. 351–7. 53 indexed citations

Inagawa, Tetsuji, et al.. (1983). Simplified immunoassays of prostaglandin E main metabolite in human urine.. PubMed. 11. 191–6. 10 indexed citations

Morimura, Tatsuo, et al.. (1983). ONO-3144, a new anti-inflammatory drug and its possible mechanism of action.. PubMed. 261(2). 316–27. 4 indexed citations

Kikkawa, Ryuichi, Ikuo Hatanaka, H. Yasuda, et al.. (1983). Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia. 24(4). 290–2. 99 indexed citations

Fujitani, Buichi, et al.. (1980). Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.. PubMed. 6. 347–9. 11 indexed citations

10.

Kawasaki, A, et al.. (1980). Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.. PubMed. 6. 331–6. 6 indexed citations

11.

Fujitani, Buichi, et al.. (1980). Effect of op 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions. Thrombosis Research. 20(5-6). 573–580. 19 indexed citations

12.

Fujitani, Buichi, et al.. (1980). Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent.. PubMed. 247(1). 89–102. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact